Development of Biomarkers for Inhibition of SLC6A19 (B(0)AT1)—A Potential Target to Treat Metabolic Disorders

Recent studies have established that dietary protein restriction improves metabolic health and glucose homeostasis. SLC6A19 (B(0)AT1) is the major neutral amino acid transporter in the intestine and carries out the bulk of amino acid absorption from the diet. Mice lacking SLC6A19 show signs of prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Javed, Kiran, Cheng, Qi, Carroll, Adam J., Truong, Thy T., Bröer, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274964/
https://www.ncbi.nlm.nih.gov/pubmed/30441827
http://dx.doi.org/10.3390/ijms19113597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274964/
https://www.ncbi.nlm.nih.gov/pubmed/30441827
http://dx.doi.org/10.3390/ijms19113597

Ejemplares similares